Wordt geladen...
Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
Severe asthma affects between 5% and 10% of patients with asthma worldwide and requires best standard therapies at maximal doses, but there is a subgroup of patients refractory to all treatments. We share a case report of a 53-year-old woman with a history of severe allergic asthma that progressivel...
Bewaard in:
| Gepubliceerd in: | Ther Clin Risk Manag |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5687776/ https://ncbi.nlm.nih.gov/pubmed/29184413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S149775 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|